← Back to All Filings

Jazz Pharmaceuticals Director Surrenders Shares for Tax Obligations

Low SignificanceSeptember 2, 2026 at 9:38:32 PM UTC

Jazz Pharmaceuticals plc

$JAZZ4CIK: 0001232524

Subscribe to track JAZZ

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

šŸ“‹ SEC Form 4 Filing Summary: Jazz Pharmaceuticals plc ($JAZZ)

šŸ‘¤ Insider: Jennifer E. Cook (Director) šŸ“… Transaction Date: August 31, 2026 šŸ’¼ Transaction Type: Tax Withholding (Code F) šŸ“‰ Shares Disposed: 1,706 šŸ’µ Average Price: ~$241.41 šŸ’° Total Value: $411,848.78 šŸ“¦ Shares Retained: 10,736

Note: Shares were sold/withheld solely to satisfy tax withholding obligations related to the vesting of restricted stock units.

Comprehensive Analysis

Insider Filing Analysis: Jazz Pharmaceuticals plc (NASDAQ: JAZZ)

Overview

On September 2, 2026, Jazz Pharmaceuticals plc filed a Form 4 report on behalf of Director Jennifer E. Cook, detailing transactions executed on August 31, 2026.

Key Transaction Details

  • Security: Ordinary Shares
  • Transaction Code: F (Payment of exercise price or tax liability by delivering or withholding securities)
  • Number of Shares: 1,706 ordinary shares disposed of across two tranches (14 shares at $244.0643 and 1,692 shares at $241.39).
  • Total Transaction Value: $411,848.78
  • Post-Transaction Beneficial Ownership: 10,736 directly held ordinary shares.

Analysis & Context

  • Nature of Transaction: Footnote (1) confirms these shares were withheld or sold strictly to satisfy tax withholding liabilities arising from the vesting of previously awarded restricted stock units (RSUs).
  • Significance: Low. The disposition represents standard non-discretionary administrative share withholding rather than an open-market insider sale driven by market sentiment.
Topics:#JAZZ#JazzPharmaceuticals#Form4#InsiderTrading#SEC

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is AI-generated from public SEC filings and may contain errors. It is for informational and educational purposes only and is not investment, legal, or tax advice.

The Filing Fool is not a registered investment adviser, broker-dealer, or financial planner. Nothing here is a recommendation or solicitation to buy, sell, or hold any security.

Always do your own due diligence and consult a licensed professional.